Industrial choices for protein production by large-scale cell culture.

Traditional barriers to large-scale mammalian culture have now been addressed, with the standard stirred-tank reactor emerging as industry's technology of choice. The issues of adapting cells to suspension culture, shear sensitivity and oxygen supply have been largely resolved. But for many low-volume and specialty applications, such as the production of viral vaccines and gene therapies, reactor technology remains diversified, with reactor types ranging from roller bottles to stacked plates and hollow fibers.

[1]  D. Lütkemeyer,et al.  Development of Serum‐Free Bioreactor Production of Recombinant Human Thyroid Stimulating Hormone Receptor , 2000, Biotechnology progress.

[2]  J Shiloach,et al.  Production of HIV‐1 gp120 in Packed‐Bed Bioreactor Using the Vaccinia Virus/T7 Expression System , 2000, Biotechnology progress.

[3]  F. Muzzio,et al.  Computational and experimental investigation of flow and fluid mixing in the roller bottle bioreactor. , 2000, Biotechnology and bioengineering.

[4]  B T Frohlich,et al.  Measurement and Control of Dissolved Carbon Dioxide in Mammalian Cell Culture Processes Using an in Situ Fiber Optic Chemical Sensor , 2000, Biotechnology progress.

[5]  S. Harvey,et al.  Monitoring Adenovirus Infections with On‐Line and Off‐Line Methods , 2000, Biotechnology progress.

[6]  M. Saedi,et al.  Large-scale propagation of recombinant adherent cells that secrete a stable form of human glandular kallikrein, hK2. , 1999, Protein expression and purification.

[7]  A J Sinskey,et al.  Large‐scale Production of Mammalian Cells and Their Products: Engineering Principles and Barriers to Scale‐up , 1983, Annals of the New York Academy of Sciences.

[8]  A Knoll,et al.  First Steps in Robot Automation of Sampling and Sample Management during Cultivation of Mammalian Cells in Pilot Scale , 2000, Biotechnology progress.

[9]  T. Ryll,et al.  A Comparison of Different Methods To Determine the End of Exponential Growth in CHO Cell Cultures for Optimization of Scale‐Up , 2000, Biotechnology progress.

[10]  Mark Lindsey,et al.  Complexity among constituents of the HLA-B*1501 peptide motif , 1998, Immunogenetics.

[11]  C. Hoy,et al.  Multiple cell culture factors can affect the glycosylation of Asn-184 in CHO-produced tissue-type plasminogen activator. , 2000, Biotechnology and bioengineering.

[12]  J. D. Yang,et al.  Achievement of high cell density and high antibody productivity by a controlled-fed perfusion bioreactor process. , 2000, Biotechnology and bioengineering.

[13]  J Tramper,et al.  Shear sensitivity of animal cells from a culture-medium perspective. , 1998, Trends in biotechnology.

[14]  C. Lamers,et al.  Large-scale production of natural cytokines during activation and expansion of human T lymphocytes in hollow fiber bioreactor cultures. , 1999, Journal of immunotherapy.

[15]  M. Perrier,et al.  293SF Metabolic Flux Analysis during Cell Growth and Infection with an Adenoviral Vector , 2000, Biotechnology progress.

[16]  A. M. Moro,et al.  Glucose uptake rate as a tool to estimate hybridoma growth in a packed bed bioreactor , 1999 .

[17]  S. R. Nathan,et al.  A systematic approach to the validation of process control parameters for monoclonal antibody production in fed-batch culture of a murine myeloma. , 2000, Biotechnology and bioengineering.

[18]  Paul W. Sauer,et al.  A high-yielding, generic fed-batch cell culture process for production of recombinant antibodies. , 2000, Biotechnology and bioengineering.

[19]  M. Schenerman,et al.  Comparability testing of a humanized monoclonal antibody (Synagis) to support cell line stability, process validation, and scale-up for manufacturing. , 1999, Biologicals : journal of the International Association of Biological Standardization.

[20]  G. F. Wagner,et al.  Expression, purification, and bioassay of human stanniocalcin from baculovirus-infected insect cells and recombinant CHO cells. , 1998, Protein expression and purification.